Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer.

Item

http://www.wikidata.org/entity/Q38834858

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer.

@en

type

Item

label

Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer.

@en

prefLabel

Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer.

@en

P1476

Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer.

@en

P2093

Murray Epstein

http://www.w3.org/2001/XMLSchema#string

P2860

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?

A comparison of the aldosterone-blocking agents eplerenone and spironolactone

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Characterization of structure and function of ZS-9, a K+ selective ion trap

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.

Enhanced large intestinal potassium permeability in end-stage renal disease.

P304

1435-1448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14656566.2016.1190333

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bertram Pitt

P577

2016-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27180623

http://www.w3.org/2001/XMLSchema#string